IL10 and schistosomiasis: Collectively, our findings suggest a novel therapeutic strategy for schistosomiasis: PKCλ/ι-targeted modulation of IL-10 signaling could represent a precision approach to simultaneously sustain antiparasitic immunity while curbing fibrosis progression.